Cancer in global health: How do prevention and early detection strategies relate?

Science Translational Medicine

Volumn 7, Issue 278, 2015, Pages

  Ilbawi, André M ^a   Anderson, Benjamin O ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; FINASTERIDE; HELICOBACTER PYLORI VACCINE; HEPATITIS B VACCINE; HEPATITIS C VACCINE; TAMOXIFEN; WART VIRUS VACCINE;

ANTIMICROBIAL THERAPY; ANTIVIRAL THERAPY; BREAST CANCER; CANCER CONTROL; CANCER DIAGNOSIS; CANCER IMMUNIZATION; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; COLON CANCER; COLORECTAL CANCER; CONCEPTUAL FRAMEWORK; COST EFFECTIVENESS ANALYSIS; DRUG APPROVAL; EARLY DIAGNOSIS; ENVIRONMENTAL PROTECTION; ESOPHAGUS CANCER; EVIDENCE BASED MEDICINE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HEALTH EDUCATION; HEALTH PROGRAM; HEALTH SERVICE; HELICOBACTER INFECTION; HEPATITIS B; HEPATITIS C; HUMAN; INTEGRATED HEALTH CARE SYSTEM; LIVER CANCER; LIVER CELL CARCINOMA; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; MASS MEDIUM; MASTECTOMY; OVARY CANCER; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; PROPHYLACTIC SURGICAL PROCEDURE; PROSTATE CANCER; PUBLIC HEALTH; REVIEW; RISK BENEFIT ANALYSIS; RISK REDUCTION; SCREENING TEST; SMOKING CESSATION; STOMACH CANCER; STRATEGIC PLANNING; UTERINE CERVIX CANCER; UTERUS CANCER; HEALTH; NEOPLASMS;

DELIVERY OF HEALTH CARE; EARLY DETECTION OF CANCER; GLOBAL HEALTH; HUMANS; NEOPLASMS;

EID: 84924559947     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3008853     Document Type: Review

References (29)

1. R. Lozano, M. Naghavi, K. Foreman, S. Lim, K. Shibuya et al., Global and regional mortality from 235 causes of Death for 20 age groups in 1990 and 2010: A systematic analysis for the Global BurDen of Disease Study 2010. Lancet 380, 2095-2128 (2012)
2. P. Vineis, C. P. Wild, Global cancer patterns: Causes and prevention. Lancet 383, 549-557 (2014)
3. R. A. Nugent, A. B. Feigl, Where have all the donors gone? Scarce donor funding for non-communicable diseases (working paper 228) (Center for Global Development, Washington, DC, 2010)
4. R. Beaglehole, R. Bonita, R. Magnusson, Global cancer prevention: An important pathway to global health and Development. Public Health 125, 821-831 (2011)
5. T. P. Kingham, O. I. Alatise, V. VanDerpuye, C. Casper, F. A. Abantanga, T. B. Kamara, O. I. OlopaDe, M. Habeebu, F. B. Abdulkareem, L. Denny, Treatment of cancer in sub-Saharan Africa. Lancet Oncol. 14, e158-e167 (2013)
6. J. Ferlay et al., GLOBOCAN 2012 v1.2, Cancer InciDence and Mortality WorldwiDe: IARC (released January 2015); http://globocan.iarc.fr (accessed February 2015)
7. P. Farmer, J. Frenk, F. M. Knaul, L. N. Shulman, G. Alleyne, L. Armstrong, R. Atun, D. Blayney, L. Chen, R. Feachem, M. GospoDarowicz, J. Gralow, S. Gupta, A. Langer, J. Lob-Levyt, C. Neal, A. Mbewu, D. Mired, P. Piot, K. S. Reddy, J. D. Sachs, M. Sarhan, J. R. Seff rin, Expansion of cancer care and control in countries of low and middle income: A call to action. Lancet 376, 1186-1193 (2010)
8. E. C. Dowling, C. KlabunDe, J. Patnick, R. Ballard-Barbash-International Cancer Screening Network (ICSN), Breast and cervical cancer screening programme implementation in 16 countries. J. Med. Screen. 17, 139-146 (2010)
9. C. De Martel, J. Ferlay, S. Franceschi, J. Vignat, F. Bray, D. Forman, M. Plummer, Global burDen of cancers attributable to infections in 2008: A review and synthetic analysis. Lancet Oncol. 13, 607-615 (2012)
10. G. A. Colditz, E. K. Wei, Preventability of cancer: The relative contributions of biologic and social and physical environmental Determinants of cancer mortality. Annu. Rev. Public Health 33, 137-156 (2012)
11. H.-O. ADami, D. J. Hunter, D. Trichopoulos, Textbook of cancer epiDemiology. Monographs in epiDemiology and biostatistics (Oxford Univ. Press, Oxford, UK, ed. 2, 2008), p. xxxiii.
12. F. M. Knaul et al., in Closing the Global Cancer DiviDe: An Equity Imperative, F. M. Knaul, J. R. Gralow, R. Atun, A. BhaDelia, Eds. (Harvard Univ. Press, Boston, 2012), pp. 29-70.
13. A. Jemal, F. Bray, D. Forman, M. OBrien, J. Ferlay, M. Center, D. M. Parkin, Cancer burDen in Africa and opportunities for prevention. Cancer 118, 4372-4384 (2012)
14. R. Sullivan, L. Homberg, A. D. Purushotham, Cancer risk and prevention in a globalised world: Solving the public policy mismatch. Eur. J. Cancer 48, 2043-2045 (2012)
15. M. J. Byron, N. K. Cobb, Concerns about a meta-analysis of computer smoking cessation programs. Arch. Intern. Med. 169, 1806-1818 (2009)
16. P. Anand, A. B. Kunnumakkara, C. SunDaram, K. B. Harikumar, S. T. Tharakan, O. S. Lai, B. Sung, B. B. Aggarwal, Cancer is a preventable disease that requires major lifestyle changes. Pharm. Res. 25, 2097-2116 (2008)
17. P. R. Portschy, K. M. Kuntz, T. M. Tuttle, Survival outcomes after contralateral prophylactic mastectomy: A Decision analysis. J. Natl. Cancer Inst. 106, dju160 (2014)
18. D. R. Aberle, A. M. ADams, C. D. Berg, W. C. Black, J. D. Clapp, R. M. Fagerstrom, I. F. Gareen, C. Gatsonis, P. M. Marcus, J. D. Sicks, National Lung Screening Trial Research Team, Reduced lung-cancer mortality with lowDose computed tomographic screening. N. Engl. J. Med. 365, 395-409 (2011)
19. P. M. McMahon, C. Y. Kong, C. Bouzan, M. C. Weinstein, L. E. Cipriano, A. C. Tramontano, B. E. Johnson, J. C. Weeks, G. S. Gazelle, Cost-eff ectiveness of computed tomography screening for lung cancer in the United States. J. Thorac. Oncol. 6, 1841-1848 (2011)
20. World Health Organization Framework Convention on Tobacco Control. Geneva Switzerland (cited 2015 February 20); available at www.who.int/fctc/en .
21. C. Tomasetti, B. Vogelstein, Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions. Science 347, 78-81 (2015)
22. D. B. Thomas, R. H. Murillo, B. O. Kardinah, AnDerson, in Cancer EpiDemiology: Low and Middle Income Countries and Special Populations, A. S. Soliman, D. Schottenfeld, P. Boffetta, Eds. (Oxford Univ. Press, New York, 2013), pp. 378-395.
23. C. H. Yip, R. A. Smith, B. O. AnDerson, A. B. Miller, D. B. Thomas, E. S. Ang, R. S. Caff arella, M. Corbex, G. L. Kreps, A. McTiernan, Breast Health Global Initiative Early Detection Panel, GuiDeline implementation for breast healthcare in low-and middle-income countries: Early Detection resource allocation. Cancer 113 (suppl.), 2244-2256 (2008)
24. G. Danaei, S. VanDer Hoorn, A. D. Lopez, C. J. Murray, M. Ezzati, Comparative Risk Assessment collaborating group (Cancers), Causes of cancer in the world: Comparative risk assessment of nine behavioural and environmental risk factors. Lancet 366, 1784-1793 (2005)
25. S. Franceschi, C. P. Wild, Meeting the global Demands of epiDemiologic transition-The indispensable role of cancer prevention. Mol. Oncol. 7, 1-13 (2013)
26. S. G. Zelle, K. M. Nyarko, W. K. Bosu, M. Aikins, L. M. Nins, J. A. Lauer, C. R. SepulveDa, J. A. Hontelez, R. Baltussen, Costs, effects and cost-eff ectiveness of breast cancer control in Ghana. Trop. Med. Int. Health 17, 1031-1043 (2012)
27. D. Wang, W. Zheng, S. M. Wang, J. B. Wang, W. Q. Wei, H. Liang, Y. L. Qiao, P. Boffetta, Estimation of cancer inciDence and mortality attributable to overweight, obesity, and physical inactivity in China. Nutr. Cancer 64, 48-56 (2012)
28. C. G. Mhlck, H. Jonsson, P. Lenner, Pap smear screening and changes in cervical cancer mortality in SweDen. Int. J. Gynaecol. Obstet. 44, 267-272 (1994)
29. G. L. Andriole, E. D. Crawford, R. L. Grubb 3rd, S. S. Buys, D. Chia, T. R. Church, M. N. Fouad, C. Isaacs, P. A. Kvale, D. J. Reding, J. L. Weissfeld, L. A. Yokochi, B. OBrien, L. R. Ragard, J. D. Clapp, J. M. Rathmell, T. L. Riley, A. W. Hsing, G. Izmirlian, P. F. Pinsky, B. S. Kramer, A. B. Miller, J. K. Gohagan, P. C. Prorok, P. P. Team, Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality results after 13 years of follow-up. J. Nat. Cancer Inst. 104, 125-132 (2012)